PMGC HOLDINGS INC
ELAB · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $3.06
- Today’s Low
- $2.85
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.06
- Previous Close
- $3.05
- Volume
- 8.63K
- Market Cap
- $2.46M
- P/E Ratio
- --
- EPS
- $-1,022.58
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Consumer products
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 120 NEWPORT CENTER DRIVE, NEWPORT BEACH, CA, UNITED STATES, 92660
- Country
- US
- Listing Date
- 2023-11-21
- Fiscal Year End
- December
- Shares Outstanding
- 4.54M
- CIK
- 0001840563
- Website
- pmgcholdings.com
Elevai Labs, Inc. (Ticker: ELAB) is an innovative technology firm at the forefront of artificial intelligence and machine learning, primarily catering to the healthcare and finance sectors. By leveraging sophisticated data analytics, the company empowers organizations to extract actionable insights from intricate datasets, thus enhancing operational efficiencies and supporting strategic decision-making. Positioned strategically within a dynamic technology landscape, Elevai Labs is well-prepared to harness emerging market trends for growth, underscoring its commitment to advancing AI technologies and solidifying its role as a significant player with strong potential for sustainable development and competitive advantage.
Financial Metrics
Revenue
2026-06-30
$1.3M
2026-03-31
$681.99K
2025-12-31
$304.13K
2025-09-30
$285.94K
Operating Expenses
2026-06-30
$3.92M
2026-03-31
$3.39M
2025-12-31
$3.01M
2025-09-30
$2.23M
Net Income
2026-06-30
-$2.94M
2026-03-31
-$4.96M
2025-12-31
-$2.98M
2025-09-30
-$2.59M
Net Profit Margin
2026-06-30
-225.11%
2026-03-31
-728.34%
2025-12-31
-980.7%
2025-09-30
-907.27%
Earnings Per Share
2026-06-30
$-0.61
2026-03-31
$-111.74
2025-12-31
$-519.17
2025-09-30
$-4.95
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.51M
2026-03-31
-$3.14M
2025-12-31
-$2.9M
2025-09-30
-$2.38M
Effective Tax Rate
2026-06-30
--
2026-03-31
0.07%
2025-12-31
-1.04%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.3M | $681.99K | $304.13K | $285.94K |
| Operating Expenses | $3.92M | $3.39M | $3.01M | $2.23M |
| Net Income | -$2.94M | -$4.96M | -$2.98M | -$2.59M |
| Net Profit Margin | -225.11% | -728.34% | -980.7% | -907.27% |
| Earnings Per Share | $-0.61 | $-111.74 | $-519.17 | $-4.95 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.51M | -$3.14M | -$2.9M | -$2.38M |
| Effective Tax Rate | -- | 0.07% | -1.04% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.